MedRx Co., Ltd
Research MedRx Co., Ltd (4586.T) on Bullrun: market cap JPY 3.64B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker4586.T
- ExchangeTSE
- CountryJapan
- SectorHealthcare
- IndustryDrug Manufacturers - Specialty & Generic
- CurrencyJPY
- Market capJPY 3.64B
- Financial periodFY2025
- RevenueJPY 128.08M
- Revenue growth-50.3%
- Net income-JPY 937.37M
- Free cash flow-JPY 970.86M
- Gross margin99.1%
Valuation Snapshot
latest market cap is JPY 3.64B.
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | JPY 128.08M | -JPY 937.37M | -JPY 970.86M | 99.1% | -17.44 | JPY 1.75B | n/a | JPY 2.05B |
| FY2024 | JPY 257.92M | -JPY 806.76M | -JPY 803.67M | 99.9% | -18.56 | JPY 1.98B | n/a | JPY 2.17B |
| FY2023 | JPY 29.53M | -JPY 932.90M | -JPY 914.56M | 91.9% | -26.82 | JPY 1.72B | n/a | JPY 1.92B |
| FY2022 | JPY 59.48M | -JPY 1.11B | -JPY 1.08B | 95.6% | -43.81 | JPY 994.03M | n/a | JPY 1.21B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | JPY 3.64B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 JPY.
About MedRx Co., Ltd
MedRx Co., Ltd, a pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan. The company develops transdermal medicines based on the ionic liquid transdermal system (ILTS) and the nano-sized colloid transdermal system (NCTS); and microneedle arrays/patch vaccines for the delivery of vaccines and APIs through the skin. Its products also include MRX-5LBT, which has NDA approval in the United States for neuropathic pain;
Related stock research
Other Healthcare stocks
Frequently asked questions
What is MedRx Co., Ltd's market cap?
MedRx Co., Ltd's market capitalization is JPY 3.64B.
What does MedRx Co., Ltd do?
MedRx Co., Ltd, a pharmaceutical formulation development company, provides pharmaceutical drugs based on the transdermal absorption system in Japan. The company develops transdermal medicines based on the ionic liquid transdermal system (ILTS) and the nano-sized colloid transdermal system (NCTS); and microneedle arrays/patch vaccines for the delivery of vaccines and APIs through the skin.